Towards Gram-positive antivirulence drugs: new inhibitors of Streptococcus agalactiae Stk1.
Towards Gram-positive antivirulence drugs: new inhibitors of Streptococcus agalactiae Stk1.
复制标题
DOI:
10.1016/j.bmcl.2010.04.150
复制
发表时间:
2010-06-15
影响因子:
2.7
通讯作者:
Higgins, Jonathan M. G.
中科院分区:
文献类型:
--
作者:
Cuny, Gregory D.;Robin, Maxime;Ulyanova, Natalia P.;Patnaik, Debasis;Pique, Valerie;Casano, Gilles;Liu, Ji-Feng;Lin, Xiangjie;Xian, Jun;Glicksman, Marcie A.;Stein, Ross L.;Higgins, Jonathan M. G.
Haspin is a serine/threonine kinase required for completion of normal mitosis that is highly expressed during cell proliferation, including in a number of neoplasms. Consequently, it has emerged as a potential therapeutic target in oncology. A high throughput screen of approximately 140,000 compounds identified an acridine analog as a potent haspin kinase inhibitor. Profiling against a panel of 270 kinases revealed that the compound also exhibited potent inhibitory activity for DYRK2, another serine/threonine kinase. An optimization study of the acridine series revealed that the structure-activity relationship (SAR) of the acridine series for haspin and DYRK2 inhibition had many similarities. However, several structural differences were noted that allowed generation of a potent haspin kinase inhibitor (33, IC50 < 60 nM) with 180-fold selectivity over DYRK2. In addition, a moderately potent DYRK2 inhibitor (41, IC50 < 400 nM) with a 5.4-fold selectivity over haspin was also identified.
登录
查看更多内容
影响因子:
1.6
作者:
Higgins JM
通讯作者:
Higgins JM
影响因子:
158.5
作者:
Dave, Sandeep S.;Fu, Kai;Staudt, Louis M.
通讯作者:
Staudt, Louis M.
影响因子:
4.8
作者:
Tanaka, H;Yoshimura, Y;Nishimune, Y
通讯作者:
Nishimune, Y
影响因子:
3.5
作者:
Polioudaki, H;Markaki, Y;Georgatos, SD
通讯作者:
Georgatos, SD
影响因子:
11.8
作者:
Dai, Jun;Sullivan, Beth A.;Higgins, Jonathan M. G.
通讯作者:
Higgins, Jonathan M. G.